CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $7,011,938
- in 3 filings, $6.7M under 10b5-1 plans
Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-09 | Sibold William John President and CEO | Sale 10b5-1 | −512 | $533.09 | $273K | 207,449 |
| 2026-09-09 | Sibold William John President and CEO | Sale 10b5-1 | −396 | $534.20 | $212K | 207,053 |
| 2026-09-09 | Sibold William John President and CEO | Sale 10b5-1 | −644 | $535.27 | $345K | 206,409 |
| 2026-09-09 | Sibold William John President and CEO | Sale 10b5-1 | −1,040 | $536.11 | $558K | 205,369 |
| 2026-09-09 | Sibold William John President and CEO | Sale 10b5-1 | −640 | $537.17 | $344K | 204,729 |
| 2026-09-09 | Sibold William John President and CEO | Sale 10b5-1 | −520 | $538.30 | $280K | 204,209 |
| 2026-09-09 | Sibold William John President and CEO | Sale 10b5-1 | −215 | $539.03 | $116K | 203,994 |
| 2026-09-09 | Sibold William John President and CEO | Sale 10b5-1 | −505 | $540.19 | $273K | 203,489 |
| 2026-09-09 | Sibold William John President and CEO | Sale 10b5-1 | −362 | $541.65 | $196K | 203,127 |
| 2026-09-09 | Sibold William John President and CEO | Sale 10b5-1 | −160 | $542.55 | $87K | 202,967 |
| 2026-08-17 | Kelley Shannon T General Counsel | Sale | −664 | $514.97 | $342K | 11,474 |
| 2026-08-15 | REED JOHN C Director | Grant or award | +647 | 647 | ||
| 2026-08-15 | REED JOHN C Director | Grant or award · Stock Option (Right to Buy) | +1,078 | 1,078 | ||
| 2026-07-20 | Sibold William John President and CEO | Sale | −140 | $542.75 | $76K | 211,689 |
| 2026-07-20 | Sibold William John President and CEO | Sale | −110 | $543.79 | $60K | 211,579 |
| 2026-07-20 | Sibold William John President and CEO | Sale | −545 | $544.71 | $297K | 211,034 |
| 2026-07-20 | Sibold William John President and CEO | Sale | −275 | $545.71 | $150K | 210,759 |
| 2026-07-20 | Sibold William John President and CEO | Sale | −269 | $547.08 | $147K | 210,490 |
| 2026-07-20 | Sibold William John President and CEO | Sale | −680 | $547.70 | $372K | 209,810 |
| 2026-07-20 | Sibold William John President and CEO | Sale | −47 | $548.87 | $26K | 209,763 |
Page 2 of 82 · 1,629 trades